bayesian methods in pharmacovigilance

bayesian methods in pharmacovigilance

ID：7284034

大小：316.43 KB

頁(yè)數(shù)：21頁(yè)

時(shí)間：2018-02-10

bayesian methods in pharmacovigilance_第1頁(yè)
bayesian methods in pharmacovigilance_第2頁(yè)
bayesian methods in pharmacovigilance_第3頁(yè)
bayesian methods in pharmacovigilance_第4頁(yè)
bayesian methods in pharmacovigilance_第5頁(yè)
資源描述：

《bayesian methods in pharmacovigilance》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在工程資料-天天文庫(kù)。

1、BayesianMethodsinPharmacovigilance*UniversityPressScholarshipOnlineOxfordScholarshipOnlineBayesianStatistics9JoséM.Bernardo,M.J.Bayarri,JamesO.Berger,A.P.Dawid,DavidHeckerman,AdrianF.M.Smith,andMikeWestPrintpublicationdate:2011PrintISBN-13:9780199694587PublishedtoOxfordScholarshipOnline:January2

2、012DOI:10.1093/acprof:oso/9780199694587.001.0001BayesianMethodsinPharmacovigilance*DavidMadiganPatrickRyanShawnSimpsonIvanZorychDOI:10.1093/acprof:oso/9780199694587.003.0014AbstractandKeywordsRegulatorssuchastheU.S.FoodandDrugAdministrationhaveelaborate,multi‐yearprocessesforapprovingnewdrugsass

3、afeandeffective.Nonetheless,inrecentyears,severalapproveddrugshavebeenwithdrawnfromthemarketbecauseofseriousandsometimesfatalsideeffects.Wedescribestatisticalmethodsforpost‐approvaldataanalysisthatattempttodetectdrugsafetyproblemsasquicklyaspossible.Bayesianapproachesareespeciallyusefulbecauseof

4、thehighdimensionalityofthedata,and,inthefuture,forincorporatingdisparatesourcesofinformation.Keywords:Drugsafety,Shrinkage,High‐dimensionalmodeling,PoissonregressionPage1of22BayesianMethodsinPharmacovigilance*SummaryRegulatorssuchastheU.S.FoodandDrugAdministrationhaveelaborate,multi‐yearprocesse

5、sforapprovingnewdrugsassafeandeffective.Nonetheless,inrecentyears,severalapproveddrugshavebeenwithdrawnfromthemarketbecauseofseriousandsometimesfatalsideeffects.Wedescribestatisticalmethodsforpost‐approvaldataanalysisthatattempttodetectdrugsafetyproblemsasquicklyaspossible.Bayesianapproachesaree

6、speciallyusefulbecauseofthehighdimensionalityofthedata,and,inthefuture,forincorporatingdisparatesourcesofinformation.KeywordsandPhrases:DRUGSAFETY;SHRINKAGE;HIGH‐DIMENSIONALMODELING;POISSONREGRESSION.1.IntroductionIncreasingscientific,regulatoryandpublicscrutinyfocusesontheobligationofthemedical

7、community,pharmaceuticalindustryandhealthauthoritiestoensurethatmarketeddrugshaveacceptablebenefit‐riskprofiles.Thisisanintricateandongoingprocessthatbeginswithcarefullydesignedrandomizedclinicaltrialspriortoapprovalbutconti

當(dāng)前文檔最多預(yù)覽五頁(yè)，下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè)，下載文檔查看全文
溫馨提示：
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫(huà)的文件，查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常，文件下載后無(wú)此問(wèn)題，請(qǐng)放心下載。
2. 本文檔由用戶上傳，版權(quán)歸屬用戶，天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容，確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載，若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤，付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。